Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study1-3

Department of Nutrition Science-Dietetics, Harokopio University, Athens, Greece.
American Journal of Clinical Nutrition (Impact Factor: 6.92). 02/2008; 87(2):424-30.
Source: PubMed

ABSTRACT Choline and betaine are found in a variety of plant and animal foods and were recently shown to be associated with decreased homocysteine concentrations.
The scope of this work was to investigate the associations between dietary choline and betaine consumption and various markers of low-grade systemic inflammation.
Under the context of a cross-sectional survey that enrolled 1514 men (18-87 y of age) and 1528 women (18-89 y of age) with no history of cardiovascular disease (the ATTICA Study), fasting blood samples were collected and inflammatory markers were measured. Dietary habits were evaluated with a validated food-frequency questionnaire, and the intakes of choline and betaine were calculated from food-composition tables.
Compared with the lowest tertile of choline intake (<250 mg/d), participants who consumed >310 mg/d had, on average, 22% lower concentrations of C-reactive protein (P < 0.05), 26% lower concentrations of interleukin-6 (P < 0.05), and 6% lower concentrations of tumor necrosis factor-alpha (P < 0.01). Similarly, participants who consumed >360 mg/d of betaine had, on average, 10% lower concentrations of homocysteine (P < 0.01), 19% lower concentrations of C-reactive protein (P < 0.1), and 12% lower concentrations of tumor necrosis factor-alpha (P < 0.05) than did those who consumed <260 mg/d. These findings were independent of various sociodemographic, lifestyle, and clinical characteristics of the participants.
Our results support an association between choline and betaine intakes and the inflammation process in free-eating and apparently healthy adults. However, further studies are needed to confirm or refute our findings.


Available from: Smaragdi Antonopoulou, Jun 11, 2015
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatic steatosis is a lipid metabolic deregulation that affects millions of people worldwide and that may lead to more severe chronic liver diseases such as steatohepatitis, hepatic fibrosis, cirrhosis, or cancer. Surprisingly, the potential of diets, food groups, foods, and/or compounds to prevent hepatic steatosis prevalence has been only rarely studied in humans. The reasons for this are unclear. Yet, plant- and animal-based foods contain several bioactive compounds that are able to limit excess fat deposits, mainly triglycerides; they are called lipotropes and are used in commercial nutritional complements such as fat burners or lipotropic complexes. Although the most recognized lipotropes are choline, betaine, myo-inositol, and methionine, and to a lesser extent carnitine, many other food compounds have the ability to exert a lipotropic effect, e.g. some B vitamins, polyphenols, fiber, and organosulfur compounds. However, while most studies have been carried out in animal models of steatosis, the few human studies that have been conducted were concerned mainly with beverages like coffee or tea and with isolated lipotropes like betaine, carnitine, and polyunsaturated fatty acids. Studies associating solid food groups or dietary patterns with hepatic steatosis have almost never been performed. Therefore, the main objectives of this chapter will be to examine the state-of-the art about human studies and lipotrope consumption, and to discuss the lipotropic potential of food products with emphasis on grain products that are both cheap and lipotrope-dense foods. The adequacy between real lipotrope consumption and human needs will also be discussed.
    Hepatic steatosis: Clinical risk factors, molecular mechanisms and treatment outcomes, Edited by Sérgio H. Santos, 09/2014: chapter Diets for preventing hepatic steatosis: pages 171-208; Nova Publishers Group Co.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Betaine, beetroot juice, and supplemental nitrate have recently been reported to improve certain aspects of exercise performance, which may be mechanistically linked to increased nitric oxide. The purpose of the present study was to investigate the effect of betaine supplementation on plasma nitrate/nitrite, a surrogate marker or nitric oxide, in exercise-trained men. We used three different study designs (acute intake of betaine at 1.25 and 5.00 grams, chronic intake of betaine at 2.5 grams per day for 14 days, and chronic [6 grams of betaine per day for 7 days] followed by acute intake [6 grams]), all involving exercise-trained men, to investigate the effects of orally ingested betaine on plasma nitrate/nitrite. Blood samples were collected before and at 30, 60, 90, and 120 min after ingestion of 1.25 and 5.00 grams of betaine (Study 1); before and after 14 days of betaine supplementation at a dosage of 2.5 grams (Study 2); and before and after 7 days of betaine supplementation at a dosage of 6 grams, followed by acute ingestion of 6 grams and blood measures at 30 and 60 min post ingestion (Study 3). In Study 1, nitrate/nitrite was relatively unaffected and no statistically significant interaction (p = 0.99), dosage (p = 0.69), or time (p = 0.91) effects were noted. Similar findings were noted in Study 2, with no statistically significant interaction (p = 0.57), condition (p = 0.98), or pre/post intervention (p = 0.17) effects noted for nitrate/nitrite. In Study 3, no statistically significant changes were noted in nitrate/nitrite between collection times (p = 0.97). Our data indicate that acute or chronic ingestion of betaine by healthy, exercise-trained men does not impact plasma nitrate/nitrite. These findings suggest that other mechanisms aside from increasing circulating nitric oxide are likely responsible for any performance enhancing effect of betaine supplementation.
    Journal of the International Society of Sports Nutrition 03/2011; 8:5. DOI:10.1186/1550-2783-8-5 · 1.50 Impact Factor